Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Boehringer Ingelheim
Cipla
Healthtrust
Julphar
Colorcon
Merck
Dow

Generated: January 18, 2019

DrugPatentWatch Database Preview

Insys Dev Co Inc Company Profile

« Back to Dashboard

What is the competitive landscape for INSYS DEV CO INC, and when can generic versions of INSYS DEV CO INC drugs launch?

INSYS DEV CO INC has two approved drugs.

There are eleven US patents protecting INSYS DEV CO INC drugs.

There are twenty-six patent family members on INSYS DEV CO INC drugs in fifteen countries and twelve supplementary protection certificates in four countries.

Summary for Insys Dev Co Inc
International Patents:26
US Patents:11
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Insys Dev Co Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Insys Dev Co Inc SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-004 Jan 4, 2012 RX Yes No 9,241,935 ➤ Sign Up Y ➤ Sign Up
Insys Dev Co Inc SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-003 Jan 4, 2012 RX Yes Yes 9,289,387 ➤ Sign Up Y ➤ Sign Up
Insys Dev Co Inc SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-005 Jan 4, 2012 RX Yes No 9,289,387 ➤ Sign Up Y ➤ Sign Up
Insys Dev Co Inc SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-005 Jan 4, 2012 RX Yes No 9,642,797 ➤ Sign Up Y ➤ Sign Up
Insys Dev Co Inc SUBSYS fentanyl SPRAY;SUBLINGUAL 202788-006 Aug 30, 2012 RX Yes No 8,835,459 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for INSYS DEV CO INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Sublingual Spray 0.4 mg/spray ➤ Subscribe 2017-05-22
➤ Subscribe Oral solution 5 mg/mL ➤ Subscribe 2017-04-17
➤ Subscribe Oral Solution 5mg/ml ➤ Subscribe 2017-04-17

Supplementary Protection Certificates for Insys Dev Co Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00523 Netherlands ➤ Sign Up PRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006
00522 Netherlands ➤ Sign Up PRODUCT NAME: FENTANYL EN DOSERINGSAPPLICATOR; REG. NO/DATE: EU/2/11/127/001 20111006
2006 00019 Denmark ➤ Sign Up PRODUCT NAME: FENTANYL HYDROCHLORID
2011000009 Germany ➤ Sign Up PRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
2006000022 Germany ➤ Sign Up PRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Accenture
Dow
Harvard Business School
Baxter
Daiichi Sankyo
QuintilesIMS
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.